SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039354
Filing Date
2023-08-08
Accepted
2023-08-08 07:09:34
Documents
52
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q coya-20230630.htm   iXBRL 10-Q 1758653
2 EX-31.1 coya-ex31_1.htm EX-31.1 29868
3 EX-31.2 coya-ex31_2.htm EX-31.2 29237
4 EX-32.1 coya-ex32_1.htm EX-32.1 21965
  Complete submission text file 0000950170-23-039354.txt   6161978

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT coya-20230630_lab.xml EX-101.LAB 347164
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT coya-20230630_cal.xml EX-101.CAL 22715
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT coya-20230630.xsd EX-101.SCH 38255
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT coya-20230630_def.xml EX-101.DEF 142231
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT coya-20230630_pre.xml EX-101.PRE 266082
46 EXTRACTED XBRL INSTANCE DOCUMENT coya-20230630_htm.xml XML 1013297
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41583 | Film No.: 231149280
SIC: 2834 Pharmaceutical Preparations